Literature DB >> 19741337

Macrophage heterogeneity in atherosclerotic plaques.

Jason L Johnson1, Andrew C Newby.   

Abstract

PURPOSE OF REVIEW: The varied behaviour of macrophages and foam cells during atherosclerosis and its clinical sequelae prompt the question whether all these activities can be the property of a single cell population. RECENT
FINDINGS: Subsets of monocytes with distinct patterns of surface markers and behaviours during inflammation have recently been characterized and shown to have complementary roles during progression of atherosclerosis. A variety of macrophage phenotypes derived from these monocyte subsets in response to mediators of innate and acquired immunity have also been found in plaques. Based on functional properties and genomic signatures, they may have different impacts on facets of plaque development, including fibrous cap and lipid core formation.
SUMMARY: Monocyte and macrophage phenotypic diversity is important in atherogenesis. More work is needed to define consistent marker sets for the different foam cell phenotypes in experimental animals and humans. Cell tracking studies are needed to establish their relationship with monocyte subtypes. In addition, genetic and pharmacological manipulation of phenotypes will be useful to define their functions and exploit the resulting therapeutic potential.

Entities:  

Mesh:

Year:  2009        PMID: 19741337      PMCID: PMC2850554          DOI: 10.1097/MOL.0b013e3283309848

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  67 in total

1.  Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII).

Authors:  T Häkkinen; K Karkola; S Ylä-Herttuala
Journal:  Virchows Arch       Date:  2000-10       Impact factor: 4.064

2.  PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties.

Authors:  M Amine Bouhlel; Bruno Derudas; Elena Rigamonti; Rébecca Dièvart; John Brozek; Stéphan Haulon; Christophe Zawadzki; Brigitte Jude; Gérard Torpier; Nikolaus Marx; Bart Staels; Giulia Chinetti-Gbaguidi
Journal:  Cell Metab       Date:  2007-08       Impact factor: 27.287

3.  Role of nuclear factor-kappa B activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo.

Authors:  Alexander J Chase; Mark Bond; Martin F Crook; Andrew C Newby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-05-01       Impact factor: 8.311

4.  Human macrophage-induced vascular smooth muscle cell apoptosis requires NO enhancement of Fas/Fas-L interactions.

Authors:  Joseph J Boyle; Peter L Weissberg; Martin R Bennett
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

5.  Shear stress-induced changes in atherosclerotic plaque composition are modulated by chemokines.

Authors:  Caroline Cheng; Dennie Tempel; Rien van Haperen; Hetty C de Boer; Dolf Segers; Martin Huisman; Anton Jan van Zonneveld; Pieter J M Leenen; Anton van der Steen; Patrick W Serruys; Rini de Crom; Rob Krams
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

6.  Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration.

Authors:  Yutaka Nakashima; Hiroshi Fujii; Shinji Sumiyoshi; Thomas N Wight; Katsuo Sueishi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-15       Impact factor: 8.311

7.  Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery.

Authors:  P Philippidis; J C Mason; B J Evans; I Nadra; K M Taylor; D O Haskard; R C Landis
Journal:  Circ Res       Date:  2003-12-01       Impact factor: 17.367

8.  Blood monocytes consist of two principal subsets with distinct migratory properties.

Authors:  Frederic Geissmann; Steffen Jung; Dan R Littman
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

9.  Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance.

Authors:  Justin I Odegaard; Roberto R Ricardo-Gonzalez; Matthew H Goforth; Christine R Morel; Vidya Subramanian; Lata Mukundan; Alex Red Eagle; Divya Vats; Frank Brombacher; Anthony W Ferrante; Ajay Chawla
Journal:  Nature       Date:  2007-05-21       Impact factor: 49.962

10.  Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors.

Authors:  F Arai; T Miyamoto; O Ohneda; T Inada; T Sudo; K Brasel; T Miyata; D M Anderson; T Suda
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

View more
  69 in total

1.  Oxidized LDL phagocytosis during foam cell formation in atherosclerotic plaques relies on a PLD2-CD36 functional interdependence.

Authors:  Ramya Ganesan; Karen M Henkels; Lucile E Wrenshall; Yasunori Kanaho; Gilbert Di Paolo; Michael A Frohman; Julian Gomez-Cambronero
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

2.  The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation.

Authors:  Jing Lin; Ming Li; Zhixiao Wang; Shaolin He; Xuming Ma; Dazhu Li
Journal:  J Lipid Res       Date:  2009-12-10       Impact factor: 5.922

3.  Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression.

Authors:  Jian-Da Lin; Hitoo Nishi; Jordan Poles; Xiang Niu; Caroline Mccauley; Karishma Rahman; Emily J Brown; Stephen T Yeung; Nikollaq Vozhilla; Ada Weinstock; Stephen A Ramsey; Edward A Fisher; P'ng Loke
Journal:  JCI Insight       Date:  2019-02-21

4.  Macrophage heterogeneity and cholesterol homeostasis: classically-activated macrophages are associated with reduced cholesterol accumulation following treatment with oxidized LDL.

Authors:  Eugene M Chu; Daven C Tai; Jennifer L Beer; John S Hill
Journal:  Biochim Biophys Acta       Date:  2012-11-08

5.  Krüppel-like factor 4 regulates macrophage polarization.

Authors:  Xudong Liao; Nikunj Sharma; Fehmida Kapadia; Guangjin Zhou; Yuan Lu; Hong Hong; Kaavya Paruchuri; Ganapati H Mahabeleshwar; Elise Dalmas; Nicolas Venteclef; Chris A Flask; Julian Kim; Bryan W Doreian; Kurt Q Lu; Klaus H Kaestner; Anne Hamik; Karine Clément; Mukesh K Jain
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

Review 6.  Immune effector mechanisms implicated in atherosclerosis: from mice to humans.

Authors:  Peter Libby; Andrew H Lichtman; Göran K Hansson
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

7.  Lipoteichoic acid isolated from Lactobacillus plantarum suppresses LPS-mediated atherosclerotic plaque inflammation.

Authors:  Joo Yun Kim; Hangeun Kim; Bong Jun Jung; Na-Ra Kim; Jeong Euy Park; Dae Kyun Chung
Journal:  Mol Cells       Date:  2013-02-21       Impact factor: 5.034

8.  Novel proteolytic microvesicles released from human macrophages after exposure to tobacco smoke.

Authors:  Chun-Jun Li; Yu Liu; Yan Chen; Demin Yu; Kevin Jon Williams; Ming-Lin Liu
Journal:  Am J Pathol       Date:  2013-03-13       Impact factor: 4.307

Review 9.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

10.  Myeloid Krüppel-like factor 4 deficiency augments atherogenesis in ApoE-/- mice--brief report.

Authors:  Nikunj Sharma; Yuan Lu; Guangjin Zhou; Xudong Liao; Parul Kapil; Puneet Anand; Ganapati H Mahabeleshwar; Jonathan S Stamler; Mukesh K Jain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-11       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.